Watch

Tweet TWEET

Listing Amsterdam Molecular Therapeutics Terminates and Company and its Shares Cease to Exist

Listing Amsterdam Molecular Therapeutics Terminates and Company and its Shares
                                Cease to Exist

  PR Newswire

  AMSTERDAM, November 16, 2012

AMSTERDAM, November 16, 2012 /PRNewswire/ --

Amsterdam Molecular Therapeutics (AMT) Holding NV in liquidation ( in
liquidatie ) (Euronext: AMT) announces that during the action period (
verzetsperiode ) no action ( verzet ) was instituted against the account and
justification ( rekening en verantwoording ) as prepared and made available
for inspection by the liquidators.

In accordance with previous announcements, as of 19 November 2012, AMT's
shares will be delisted from NYSE Euronext in Amsterdam, with 16 November 2012
being the last trading date. On 19 November 2012, AMT's liquidation shall be
finalised and the legal entity AMT shall cease to exist. As a consequence of
AMT ceasing to exist, all AMT shares shall also cease to exist on 19 November
2012, without any (further) distribution or compensation to their holders. AMT
shareholders that hold their AMT shares in book entry form will have their
position in AMT shares in their securities account struck and deleted as per
19 November 2012. To the extent that AMT shares still may appear in your
securities account after 19 November 2012, this will be for administrative
purposes only, as the AMT shares proper shall then no longer exist.

On March 30, 2012, an extraordinary general meeting of shareholders approved a
major corporate restructuring and financing transaction involving the disposal
of the Group's entire business and operations to uniQure B.V. and the
subsequent dissolution, liquidation and delisting of AMT (in liquidation).

PRN NLD

Contact: For further enquiries: Jörn Aldag, Liquidator, Amsterdam Molecular
Therapeutics (AMT) Holding NV in liquidatie (in liquidation), Tel :
+31-20-566-8014, j.aldag@amtbiopharma.com
 
Press spacebar to pause and continue. Press esc to stop.